Chinreal Awarded the Qualification of "Specialized and Special New" Enterprise in Guangdong Province in 2022.

On March 15, 2023, the Shenzhen Small and Medium-sized Enterprise Service Bureau announced the 2022 list of Shenzhen's "specialized, special and new" small and medium-sized enterprises. With its excellent comprehensive strength, Zhenrui Bio stood out among many enterprises in the industry and successfully obtained Shenzhen "Specialized, Special and New Small and Medium-sized Enterprises" qualification certification.

Since Shenzhen is a city under separate state planning, "Shenzhen Specialized and Special New Enterprises" and "Guangdong Specialized and Special New Enterprises" belong to the same level.

the "specialized, special and new" small and medium-sized enterprise cultivation project, that is, the state encourages enterprises to deeply cultivate subdivided fields and develop in the direction of "specialization, refinement, characteristics and novelty. "Specialized and special new" enterprises are excellent enterprises that focus on market segmentation, strong innovation ability, high market share, master key core technologies, and excellent quality and efficiency.

Shenzhen Zhenrui Biotechnology Co., Ltd. has maintained its original intention since its establishment in 2013. It has always adhered to the concept of "improving product performance, improving quality control ability and improving service quality are always on the way", and has continued to cultivate in the field of veterinary diagnosis.

Company currently has six technology platforms for monoclonal antibody screening and preparation, genetic engineering antibody, recombinant protein prokaryotic/eukaryotic expression, enzyme-linked immunosorbent assay, immunochromatography and nucleic acid detection, as well as three 10,000-level clean rooms and two 100,000-level clean rooms. A GMP standard purification workshop with three production lines of molecular reagent, enzyme reagent and lateral chromatography test strip has been built. It has successively passed the veterinary drug GMP, ISO9001 and ISO13485 quality management system certification and ISO14001 environment system certification, and has been recognized as a national high-tech enterprise. At the same time, Zhenrui Biology attaches great importance to industry-university-research cooperation, and has carried out project development cooperation with the School of Animal Science and Technology of Southwest University, the School of Food of South China Agricultural University and other institutions, and on this basis has jointly built a joint training base for graduate students.

Company has a wide range of products, covering more than 160 in vitro diagnostic reagents for infectious diseases of companion animals (dogs, cats) and economic animals (pigs, cattle, sheep, poultry). Zhenrui Biology is one of the first enterprises in China to obtain the approval for the production of nucleic acid fluorescence PCR detection reagent for African swine fever virus. The performance index of this product independently developed by the company is not inferior to that of imported similar reagents, which has contributed an important force to the prevention and control of African swine fever in China. At the same time, the new coronavirus antigen rapid detection card independently developed by the company has passed the European Union other medical device certification (CE qualification) and sold to many countries and regions, it also played an important role in the prevention and control of the new crown epidemic.

This time, Shenzhen Zhenrui Biotechnology Co., Ltd. can be awarded the "Specialized and Special New" enterprise certification, which not only demonstrates the comprehensive strength and corporate characteristics of Zhenrui Biotechnology, but also marks a new level of company development. At the same time, it also said that Zhenrui biology has made certain advantages in the field of veterinary drug diagnosis. It has professional diagnostic reagent products, refined enterprise management mode, characteristic technical resources and novel independent innovation mode, which is an important reason for the company to be rated as "specialized and special new" enterprises.

is not only the high affirmation and recognition of Shenzhen municipal government departments on the technical content of Zhenrui biological products, independent innovation ability and enterprise management level, but also the driving force to encourage and spur the company to continue to work hard. The company will continue to join hands with all employees to forge ahead and create a better future for Zhenrui!